Premium
Morganella morganii: A Newly Reported, Rare Cause of Neonatal Sepsis
Author(s) -
Salen Philip N.,
Eppes Stephen
Publication year - 1997
Publication title -
academic emergency medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 124
eISSN - 1553-2712
pISSN - 1069-6563
DOI - 10.1111/j.1553-2712.1997.tb03765.x
Subject(s) - morganella morganii , medicine , neonatal sepsis , antibiotics , sepsis , microbiology and biotechnology , enterobacteriaceae , pathogen , cephalosporin , aminoglycoside , pediatrics , immunology , biology , escherichia coli , genetics , gene
This case report reviews the clinical course of an 11‐day‐old boy who developed late‐onset neonatal sepsis secondary to a rare neonatal pathogen, Morganella morganii . This gram‐negative enteric bacterium, within the Enterobacteriaceae family, has most commonly been a nosocomial pathogen in debilitated, postsurgical patients. Like many other Enterobacteriaceae, M. morganii has an inducible β‐lactamase and is resistant to multiple antibiotics. When caring for neonates with culture‐proven M. morganii sepsis, the authors recommend administering both a third‐generation cephalosporin and an aminoglycoside to ensure that both antibiotics are bactericidal and to reduce the induction of resistance.